Expecting trading halt tomorrow morning going into webinar. Expecting discussion of collaboration with HPV vaccine, discussion of results and potential partnerships for HSV2, but nothing concrete yet. May talk about all this in context of the platform. Not expecting any large upfronts at this point. GLTAH
Ann: HSV-2 Phase IIa Results Investor Webinar, page-266
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.00 |
Change
0.800(7.84%) |
Mkt cap ! $224.2M | |||
| Open | High | Low | Value | Volume |
| $10.20 | $11.34 | $10.16 | $160.5K | 15.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1079 | $10.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.33 | 748 | 2 |
View Market Depth
| Last trade - 14.54pm 06/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |